TY - JOUR
T1 - Estrogen producing ovarian fibrosarcoma
T2 - A case report
AU - Miura, Mayo
AU - Suzuki, Shiro
AU - Shibata, Kiyosumi
AU - Kajiyama, Hiroaki
AU - Kikkawa, Fumitaka
N1 - Publisher Copyright:
© 2018, Nagoya University.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Fibrosarcoma is an extremely rare malignant sex-cord stromal tumor. Fibrosarcoma is generally unknown as an estrogen producing tumor. This report presents, for the first time, a case of estrogen producing ovarian fibrosarcoma in an 83-year-old female. We performed total hysterectomy, bilateral salpingo-oophorectomy and omentectomy. Histopathologically, the tumor of the left ovary had high cellularity, cellular atypia and 10-15 mitotic counts per 10 high power fields. The tumor contained small components composed of cells that were similar to Sertoli cells. In an effort to examine which component was producing estrogen, we checked aromatase expression; but both components were positive. We could not explain which component was producing estrogen. Postoperative clinical stage was IA. As she was geriatric patient, we did not recommend adjuvant chemotherapy. There were no signs of recurrence or increase in serum estradiol level at two years after the operation.
AB - Fibrosarcoma is an extremely rare malignant sex-cord stromal tumor. Fibrosarcoma is generally unknown as an estrogen producing tumor. This report presents, for the first time, a case of estrogen producing ovarian fibrosarcoma in an 83-year-old female. We performed total hysterectomy, bilateral salpingo-oophorectomy and omentectomy. Histopathologically, the tumor of the left ovary had high cellularity, cellular atypia and 10-15 mitotic counts per 10 high power fields. The tumor contained small components composed of cells that were similar to Sertoli cells. In an effort to examine which component was producing estrogen, we checked aromatase expression; but both components were positive. We could not explain which component was producing estrogen. Postoperative clinical stage was IA. As she was geriatric patient, we did not recommend adjuvant chemotherapy. There were no signs of recurrence or increase in serum estradiol level at two years after the operation.
UR - http://www.scopus.com/inward/record.url?scp=85062917750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062917750&partnerID=8YFLogxK
U2 - 10.18999/nagjms.81.1.171
DO - 10.18999/nagjms.81.1.171
M3 - Article
C2 - 30962667
AN - SCOPUS:85062917750
SN - 0027-7622
VL - 81
SP - 171
EP - 176
JO - Nagoya journal of medical science
JF - Nagoya journal of medical science
IS - 1
ER -